Drug Shortage Report for ABSORICA LD
Report ID | 206734 |
Drug Identification Number | 02539071 |
Brand name | ABSORICA LD |
Common or Proper name | ISOTRETINOIN CAPSULES |
Company Name | SUN PHARMACEUTICAL INDUSTRIES LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | ISOTRETINOIN |
Strength(s) | 32MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 30's |
ATC code | D10BA |
ATC description | ANTI-ACNE PREPARATIONS FOR SYSTEMIC USE |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2023-09-29 |
Estimated end date | Unknown |
Actual end date | 2023-11-20 |
Shortage status | Resolved |
Updated date | 2023-11-21 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | SUN HOUSE, PLOT 201 B/1, WESTERN EXPRESS HIGHWAY, GOREGAON (E) MUMBAI, MAHARASHTRA INDIA 400063 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2023-11-21 | French | Compare |
v3 | 2023-11-21 | English | Compare |
v2 | 2023-10-10 | French | Compare |
v1 | 2023-10-10 | English | Compare |
Showing 1 to 4 of 4